(Total Views: 812)
Posted On: 01/07/2022 8:39:06 AM
Post# of 148892
This is my theory on CYDY and why it is where it is. It is not uncommon to see this in big stakes pharma. Taken from poster whom I follow from when we both had IMMU and am invested in SAVA now. Same crap, different company. The problem is it is business as usual and it’s all about money, not saving lives. Contrary to his position, I tend to believe BP is involved in our situation. Excerpt below:
have resisted the idea that BP is involved, but at this point I am inclined to agree with Springer that the perp is the negotiating partner, who of course has enlisted a hedge fund to execute the plan. Knock down the stock price artificially as if the public has lost all confidence, meanwhile discrediting the company, the science, the mechanism of action relentlessly on all fronts. On something potentially worth 200+ billion in market cap, you might easily save a billion dollars or more. If this were simply a short play, they would have covered long ago and switched to the long side.
SavaDx seems to be a negotiating point. The company went from freely promoting SavaDx to stating recently that they were currently not pursuing it. And now this! Another 180° flip. (See below, from the company Website) Back in play. Sure smells like licensing negotiations.
This stock is being obliterated. Obviously, as evidenced by Schwab, no more shares are available to short. In fact naked shorts, which surely dwarf legally borrowed shorts, are probably maxed out, because naked is the preferred method-- no borrowing cost. Someone estimated there to be 500 million naked shorts against this stock. If that is true, a market maket is definitely involved. They have legal privilege.
Springer makes a compelling case that Point 72 is behind this. My theory is that they recruited not only a market maker, but also Citadel with whom they are as thick as thieves. I have already presented Citadel's activity in SAVA in the last quarter from their 13F.
have resisted the idea that BP is involved, but at this point I am inclined to agree with Springer that the perp is the negotiating partner, who of course has enlisted a hedge fund to execute the plan. Knock down the stock price artificially as if the public has lost all confidence, meanwhile discrediting the company, the science, the mechanism of action relentlessly on all fronts. On something potentially worth 200+ billion in market cap, you might easily save a billion dollars or more. If this were simply a short play, they would have covered long ago and switched to the long side.
SavaDx seems to be a negotiating point. The company went from freely promoting SavaDx to stating recently that they were currently not pursuing it. And now this! Another 180° flip. (See below, from the company Website) Back in play. Sure smells like licensing negotiations.
This stock is being obliterated. Obviously, as evidenced by Schwab, no more shares are available to short. In fact naked shorts, which surely dwarf legally borrowed shorts, are probably maxed out, because naked is the preferred method-- no borrowing cost. Someone estimated there to be 500 million naked shorts against this stock. If that is true, a market maket is definitely involved. They have legal privilege.
Springer makes a compelling case that Point 72 is behind this. My theory is that they recruited not only a market maker, but also Citadel with whom they are as thick as thieves. I have already presented Citadel's activity in SAVA in the last quarter from their 13F.
(10)
(0)Scroll down for more posts ▼
